Modeling Graves’ Orbitopathy in Experimental Graves’ Disease

Hormone and Metabolic Research - Germany
doi 10.1055/s-0035-1564108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

The Amsterdam Declaration on Graves' Orbitopathy

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

The Amsterdam Declaration on Graves' Orbitopathy

2017English

THERAPY OF ENDOCRINE DISEASE: Endocrine Dilemma: Management of Graves’ Orbitopathy

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2016English

Clinical Assessment of Patients With Graves' Orbitopathy

Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor
2011English

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Mesenchymal Stem Cell–Like Properties of Orbital Fibroblasts in Graves' Orbitopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Thymic Hyperplasia in Graves’ Disease

Clinics
Medicine
2011English

Thymic Hyperplasia in Graves’ Disease

Endocrinology & Metabolic Syndrome
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy